Renal transplant rejection markers
- 5 September 2007
- journal article
- review article
- Published by Springer Nature in World Journal of Urology
- Vol. 25 (5) , 445-455
Abstract
Acute rejection is one of the key factors which determine long-term graft function and survival in renal transplant patients. Timely detection and treatment of rejection is therefore, an important goal in the post-transplant surveillance. The standard care with serum creatinine measurements and biopsy upon allograft dysfunction implies that acute rejection is detected in an advanced stage. Therefore, non-invasive monitoring for acute rejection by markers in blood and urine has been tried over the past decades. This review describes the requirements that should be met by non-invasive markers. The experience with single biomarkers and with newer approaches—mRNA expression analysis, metabolomics, and proteomics—will be discussed, including future directions of necessary research.Keywords
This publication has 74 references indexed in Scilit:
- Banff ’05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (’CAN’)American Journal of Transplantation, 2007
- Heightened Expression of the Cytotoxicity Receptor NKG2D Correlates with Acute and Chronic Nephropathy After Kidney TransplantationAmerican Journal of Transplantation, 2006
- Long-Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?American Journal of Transplantation, 2004
- Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejectionKidney International, 2003
- CD69 EXPRESSION ON PERIPHERAL CD8 T CELLS CORRELATES WITH ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTSTransplantation, 2003
- Protocol biopsy: what is the rationale and what is the evidence?Nephrology Dialysis Transplantation, 2003
- Circulating Endothelial Cells Are a Novel Marker of Cyclosporine-Induced Endothelial DamageHypertension, 2003
- Noninvasive Diagnosis of Renal-Allograft Rejection by Measurement of Messenger RNA for Perforin and Granzyme B in UrineNew England Journal of Medicine, 2001
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Renal allograft rejection: the temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1Transplant International, 1995